Private Equity
2 min read · 24 May 2018
Scholar Rock, a biotech company focused on developing medicines that treat serious diseases, has raised over $75 million for its IPO after pricing its 5.36 million shares at $14 per share. The stock began trading May 24, 2018 on the NASDAQ under the ticker symbol of “SRRK." Jefferies LLC, Cowen and Company LLC and BMO Capital Markets Corp are the lead underwriters. Scholar Rock's pre-IPO investors included Invus, Redmile Group, Polaris Partners, ARCH Venture Partners, EcoR1 Capital, The Kraft Group, Fidelity Management and Research Company and Cormorant Asset Management.
3 min read · 24 May 2018
Bermuda and Lexington, Massachusetts-based Kiniksa Pharmaceuticals, a biopharmaceutical company, has raised about $152.6 million for its IPO after pricing its over 8.4 million shares at $18 per share. The stock began trading May 24, 2018 on the NASDAQ under the ticker symbol “KNSA.” Goldman Sachs and J.P. Morgan Securities LLC are the lead underwriters. Kiniksa's pre-IPO backers included Baker Brothers and Arrowpoint Funds.
2 min read · 24 May 2018
Ann Arbor, Michigan-based Strata Oncology, a precision oncology platform company, has secured $26 million in Series B funding. The investors included Pfizer Ventures, Merck Global Health Innovation Fund, Deerfield Management, Renaissance Venture Capital Fund, Arboretum Ventures and Baird Capital.
1 min read · 24 May 2018
Hercules Capital has agreed to provide debt financing of up to $40 million to TransEnterix Inc, a medical device company. Armentum Partners was financial adviser to TransEnterix on the transaction.
3 min read · 24 May 2018
Vance Street Capital has sold Fermatex Vascular Technologies to Spectrum Plastics Group. No financial terms were disclosed. Based in Wall, New Jersey, Fermatex is a maker of high pressure braided tubing and complex medical extrusions.
3 min read · 24 May 2018
The Firmament Group has teamed up with over thirty multi-specialty ophthalmologists and optometrists to form Vision Integrated Partners, an integrated management services organization serving the ophthalmology sector. No financial terms were disclosed. Firmament and Cadence Bank provided the financing for this transaction.
3 min read · 23 May 2018
Healthcare-focused private equity firm Consonance Capital Partners has teamed up with Jay Mohr to launch a specialty pharmaceutical initiative. Mohr was a co-founder and former managing director of Locust Walk Partners.
3 min read · 22 May 2018
3 min read · 21 May 2018
Select Dermatology, which was formed to acquire and operate North American dermatology practices, has made an undisclosed investment in Dallas-based Mindful Dermatology PLLC, a provider of dermatology physician services. Select was launched by Welsh, Carson, Anderson & Stowe and Riata Capital Group.
5 min read · 21 May 2018
